Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review

Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review Dual antiplatelet therapy (DAPT) consisting of aspirin combined with a P2Y12 receptor inhibitor has been the standard of care for several decades in patients undergoing percutaneous coronary intervention (PCI) with implantation of coronary stents. According to current guidelines from the American College of Cardiology and American Heart Association (AC...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research